Clearmind Medicine Inc. Common Shares (CMND : NASDAQ)
Common Stock
$6.00
USD
+5.29 (739.16%)
Last updated: 2026-10-05
Follow CMND
CMND
Clearmind Medicine Inc. Common Shares
WealthAwesomePerformance
1 Day
+739.16%
1 Week
+661.71%
1 Month
+417.24%
YTD
+91.08%
Key Statistics
Market Cap
$2.41M
52W High
$480.00
52W Low
$0.71
P/E Ratio
-
50 Day MA
$1.38
200 Day MA
$8.28
Beta
-1.14
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/5/2026 | $5.93 | $6.54 | $5.25 | $6.00 | $6.00 | 84,844 |
| 10/2/2026 | $0.74 | $0.74 | $0.71 | $0.71 | $0.71 | 97,400 |
| 10/1/2026 | $0.75 | $0.76 | $0.71 | $0.72 | $0.72 | 221,337 |
| 9/30/2026 | $0.81 | $0.84 | $0.80 | $0.81 | $0.81 | 31,420 |
| 9/29/2026 | $0.78 | $0.82 | $0.78 | $0.81 | $0.81 | 41,481 |
| 9/28/2026 | $0.80 | $0.82 | $0.78 | $0.79 | $0.79 | 88,997 |
| 9/25/2026 | $0.84 | $0.84 | $0.80 | $0.80 | $0.80 | 56,700 |
| 9/24/2026 | $0.85 | $0.85 | $0.80 | $0.81 | $0.81 | 62,430 |
| 9/23/2026 | $0.80 | $0.85 | $0.78 | $0.85 | $0.85 | 352,456 |
| 9/22/2026 | $0.78 | $0.79 | $0.77 | $0.78 | $0.78 | 65,870 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CMND's historical volatility
30-Day Vol
640.0%
Annualized
90-Day Vol
407.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$7.17
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$6.37 | US$0.70 – US$57.94 |
| 60 trading days | US$6.76 | US$0.30 – US$153.49 |
| 90 trading days | US$7.17 | US$0.16 – US$328.64 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Clearmind Medicine Inc. Common Shares
Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, the company has a strategic collaboration with SciSparc Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem, Polyrizon Ltd., and NeuroThera Labs Inc. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-8.86M
- Profit Margin
- 0.00%
- ROE (TTM)
- -106.98%
- EPS (Diluted)
- -57.79
- Book Value
- 6.04
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About CMND.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| GUTS | Fractyl Health, Inc. Common Stock | $4.56 | +1020.39% |
| AMPGZ | Amplitech Group, Inc. Series B Right | $0.24 | +74.48% |
| VEEA | Veea Inc. | $5.72 | +71.77% |
| PDSB | PDS Biotechnology Corp | $1.20 | +60.21% |
| BEAT | Heartbeam Inc | $0.65 | +50.39% |
| RITRF | Reitar Logtech Holdings Limited | $0.01 | +42.86% |
| QTEX | QTREX Quantum Ltd. | $1.54 | +40.00% |
| SGLY | Singularity Future Technology Ltd | $0.98 | +34.23% |